Search Results - james+luyendyk

1 Results Sort By:

Direct Thrombin Inhibitors for Diet-Induced Obesity and Fatty Liver Disease

Executive SummaryNon-alcoholic fatty liver disease (NALFD) affects approximately 20% of US adults and nearly 75% of obese adults. As NALFD becomes more severe, non-alcoholic steatohepatitis (NASH) develops, which can lead to liver failure. The only ways to treat these diseases are through weight loss, or in extreme cases, liver transplants. Researchers...
Published: 12/12/2016   |   Inventor(s): James Luyendyk
Keywords(s):   Category(s): Medical, Pharmaceutical